Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

OBJECTIVES: To evaluate the potential prognostic utility of pretreatment systemic immune-inflammation index (SII) in newly diagnosed glioblastoma multiforme (GBM) patients who underwent postneurosurgical radiotherapy and concurrent plus adjuvant temozolomide. METHODS: The retrospective data of GBM p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mediators Inflamm
Autors principals: Topkan, Erkan, Besen, Ali Ayberk, Ozdemir, Yurday, Kucuk, Ahmet, Mertsoylu, Huseyin, Pehlivan, Berrin, Selek, Ugur
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7262659/
https://ncbi.nlm.nih.gov/pubmed/32565725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4392189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars